EFFECTIVENESS AND SAFETY OF INFLIXIMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS FROM A LONGITUDINAL OBSERVATIONAL REGISTRY

被引：0
|
作者：
Rahman, Proton [1 ]
Haaland, Derek [2 ]
Sholter, Dalton [3 ]
Starr, Michael [4 ]
Karasik, Artthur
Teo, Michelle
Dixit, Sanjay [5 ]
Masetto, Ariel [6 ]
Jarosynska, Anna
Boulos, Pauline
Rampakakis, Emmanouil [7 ]
Asin-Milan, Odalis [8 ]
Lehman, Allen J. [8 ]
Nantel, Francois [8 ]
机构：
[1] Mem Univ, St John, NF, Canada
[2] Waterside Clin, Barrie, ON, Canada
[3] Rheumatol Res Assoc, Edmonton, AB, Canada
[4] McGill Univ, Montreal, PQ, Canada
[5] Arthrit Ctr, Burlington, ON, Canada
[6] Ctr Hosp Univ Sherbrooke, Sherbrooke, PQ, Canada
[7] JSS Med Res, Montreal, PQ, Canada
[8] Janssen Inc, Toronto, ON, Canada
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
101
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [31] INFECTION RISK IN ANKYLOSING SPONDYLITIS: RESULTS FROM A LONGITUDINAL OBSERVATIONAL COHORT
    Wallis, D.
    Thavaneswaran, A.
    Haroon, N.
    Ayearst, R.
    Inman, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 524 - 524
  • [32] Ongoing clinical effectiveness and safety of treatment with Infliximab in patients with ankylosing Spondylitis over 6 years
    Baraliakos, X.
    Listing, J.
    Fritz, C.
    Alten, R.
    Burmester, G.
    Krause, A.
    Schewe, S.
    Schneider, S.
    Soerensen, H.
    Zeidler, H.
    Sieper, J.
    Braun, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 51 - 51
  • [33] Effectiveness and safety of radium chloride in the treatment of ankylosing spondylitis. Results of an observational study
    Alberding, A.
    Stierle, H.
    Brandt, J.
    Braun, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2006, 65 (03): : 245 - 251
  • [34] EFFICACY AND SAFETY OF LOW-DOSE INFLIXIMAB IN ANKYLOSING SPONDYLITIS
    Schaufelberger, C.
    Morck, B.
    Jacobsson, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 642 - 643
  • [35] Predictors of Response in Patients with Ankylosing Spondylitis Treated with Infliximab or Golimumab in a Real-World Setting
    Bessette, Louis
    Kapur, Suneil
    Zummer, Michel
    Starr, Michael
    Choquette, Denis
    Sheriff, Maqbool
    Olszynski, Wojciech
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Osborne, Brendan
    Maslova, Karina
    Nantel, Francois
    Lehman, Allen
    Tkaczyk, Cathy
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1197 - 1197
  • [36] PREDICTORS OF RESPONSE IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH INFLIXIMAB OR GOLIMUMAB IN A REAL-WORLD SETTING
    Bessette, L.
    Kapur, S.
    Zummer, M.
    Starr, M.
    Choquette, D.
    Sheriff, M.
    Olszynski, W.
    Rampakakis, E.
    Psaradellis, E.
    Osborne, B.
    Maslova, K.
    Nantel, F.
    Lehman, A. J.
    Tkaczyk, C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1131 - 1131
  • [37] Profiles of Switches in Patient with Ankylosing Spondylitis: Comparing Adalimumab, Etanercept, Infliximab, Golimumab and Certolizumab.
    Raynauld, Jean-Pierre
    Bessette, Louis
    Choquette, Denis
    Fortin, Isabelle
    Haraoui, Boulos
    Pelletier, Jean-Pierre
    Remillard, Marie-Anais
    Sauvageau, Diane
    Villeneuve, Edith
    Coupal, Louis
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1123 - S1123
  • [38] Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis
    Rahman, Proton
    Choquette, Denis
    Bensen, William G.
    Khraishi, Majed
    Chow, Andrew
    Zummer, Michel
    Shaikh, Saeed
    Sheriff, Maqbool
    Dixit, Sanjay
    Sholter, Dalton
    Psaradellis, Eliofotisti
    Sampalis, John S.
    Letourneau, Vincent
    Lehman, Allen J.
    Nantel, Francois
    Rampakakis, Emmanouil
    Otawa, Susan
    Shawi, May
    BMJ OPEN, 2016, 6 (04):
  • [39] The cost-effectiveness of infliximab (Remicade®) in the treatment of ankylosing spondylitis in Canada
    Kobelt, G
    Andlin-Sobocki, P
    Maksymowych, WP
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (04) : 732 - 740
  • [40] The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade®)
    Kobelt, G
    Andlin-Sobocki, P
    Brophy, S
    Jönsson, L
    Calin, A
    Braun, J
    RHEUMATOLOGY, 2004, 43 (09) : 1158 - 1166
12345